SMAshing My Limits

Tracey Dawson, PhD, SVP, U.S. Therapeutic Area Head of Neuroscience at Novartis, discusses the SMAshing My Limits campaign.     Spinal muscular atrophy (SMA) is a group of genetic neuromuscular disorders that affect the motor neurons. The loss of motor...

Recordati’s Presentations at ENDO 2025

Mario Maldonado, MD, Global Head of Clinical Development for Endocrinology at Recordati Rare Diseases, discusses Recordati’s presentations at ENDO 2025.     LINC6 Clinical Trial LINC 6 is an ongoing, prospective observational study evaluating the long-term...

Recordati Rare Disease Initiatives

Mohamed Ladha, President and General Manager for Recordati Rare Diseases North America, discusses the company’s rare disease initiatives.     The U.S. branch of Recordati was established in 2013 with a focus on products to treat patients with rare inherited...